Usefulness of acute phase proteins for monitoring development of hepatocellular carcinoma in hepatitis B virus carriers

West African Journal of Medicine

Volumn 24, Issue 2, 2005, Pages 124-127

  Otegbayo, J A ^a   Arinola, O G ^b   Aje, A ^a   Oluwasola, O A ^b   Okiwelu, O H ^b   Salimonu, L S ^b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Acute phase proteins; Hepatitis B carriers; Hepatocellular carcinoma; Usefulness

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 2 MACROGLOBULIN; HAPTOGLOBIN; TRANSFERRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HEPATITIS B; HUMAN; IMMUNODIFFUSION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PATIENT MONITORING; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; TRANSFERRIN BLOOD LEVEL;

EID: 23044473426     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: 10.4314/wajm.v24i2.28181     Document Type: Article

References (15)

1. Beasley RP. Hepatitis B virus: The major aetiology of hepatocellular carcinoma. Cancer. 1988; 61:1942-1956.
2. Villeneuve JP, Desrochers M, Infante-Rivard C, Willems B, Raymond G, Bourcier M, Cote J, Richer G. A long-term follow-up study of asymptomatic hepatitis B surface antigen positive carriers in Montreal. Gastroenterology. 1994; 106:1000-1005.
3. Reid AE, Liang TJ. The search for the ultimate screening test for hepatocellular carcinoma continues. Hepatology. 1994; 19:255-257.
4. Shiota G, Umeki K, Okano J, Kawasaki H. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases. J. Med. 1995; 26:295-308.
5. Lin ZY, Wang LY, Yu ML, Chen SC, Chuang WL, Hsieh MY, Tsai JF, Chang WY. Role of serum C-reactive protein as a marker of hepatocellular carcinoma in patients with cirrhosis. J. Gastroenterol Hepatol.2000; 15:417-421.
6. Nath N, Dodd RY and Fang CT. Enzyme linked immunoassay for hepatitis B surface antigen- an evaluation of commercial test kit. Transfusion. 1983; 23:45-48.
7. Salimonu LS, Ladipo OA, Adeniran SO, Osunkoya BO. Serum immunoglobulin levels in normal, premature and postmature newborns and their mothers. Int. J. Obst. Gyn. 1978. 16:119-123.
8. Perrillo RP. Hepatitis B transmission and natural history. Gut. 1993, 32(2 suppl): S48-S49).
9. Oyeyinka GO, Salimonu LS. Levels of complements, immunoglobulins and acute phase proteins in plasma during aging in Nigeria. Afr. J. Med. med sci. 1999; 28:177-180.
10. Wang Y, Kinzie E, Berger FG, Lim SK, Baumann H. Haptoglobin, an inflammation-inducible plasma protein. Redox Rep. 2001; 6: 379-385.
11. Arekuul S, Chantachum Y, Matrakul D. Serum haptoglobin levels in patients with liver diseases. Southeast Asian J. Trop. Med. Pub. Health. 1974, 5:601-602.
12. Okuda M, Tokunaga B, Taketani S. Expression of haptoglobin receptors in human hepatoma cells. Biochem Biophys Acta. 1992;1136:143-149.
13. Lin J. Immunohistochemical study of transferrin receptor expression in hepatocellular carcinoma. Zhonghua Yi Xue Za Zhi. 1992; 72:86-87.
14. Suzuki Y, Aoyagi Y, Mori S, Suda T, Naitoh A, Isokawa O, Yanagi M, Igarash, Asakura H. Microheterogeneity of serum transferrin in the diagnosis of hepatocellular carcinoma. J. Gastroenterol Hepatol. 1996; 11: 358-365.
15. Meliconi R, Parracino O, Facchini A, Morselli-Labate AM, Bortolotti F, Tremolada F, Martuzzi M, Miglio F, Gasbarrini G.. Acute phase proteins in chronic and malignant liver diseases. Liver. 1988; 8:65-74.